This table provides metadata for the actual indicator available from Uganda statistics closest to the corresponding global SDG indicator. Please note that even when the global SDG indicator is fully available from Ugandan statistics, this table should be consulted for information on national methodology and other Ugandan-specific metadata information.
| Goal |
Goal 3: Ensure healthy lives and promote well-being for all at all ages |
|---|---|
| Target |
Target 3.b: Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all. |
| Indicator |
Indicator 3.b.1: Proportion of the target population covered by all vaccines included in their national program |
| Metadata update |
November 2021 |
| Related indicators |
Indicators 3.8.1: |
| Data reporter |
Uganda Bureau of Statistics |
| Organisation |
Uganda Bureau of Statistics |
| Contact person(s) |
Johnstone Galande |
| Contact organisation unit |
Department of Demography and Social Statistics |
| Contact person function |
Senior Demographer |
| Contact phone |
+256 782 789787 |
| Contact mail |
P.O Box 7186, Kampala |
| Contact email | |
| Definition and concepts |
Coverage of DTP containing vaccine (3rd dose): Percentage of surviving infants who received the 3 doses of diphtheria and tetanus toxoid with pertussis containing vaccine in a given year. Coverage of Measles containing vaccine (2nd dose): Percentage of children who received two dose of measles containing vaccine according to nationally recommended schedule through routine immunization services in a given year. Coverage of Pneumococcal conjugate vaccine (last dose in the schedule): Percentage of surviving infants who received the nationally recommended doses of pneumococcal conjugate vaccine in a given year. Coverage of Polio vaccine Percentage of children who received three doses of oral polio vaccine according to nationally recommended schedule through routine immunization programmes. Coverage of HPV vaccine (last dose in the schedule): Percentage of 15 years old girls received the recommended doses of HPV vaccine. Currently performance of the programme in the previous calendar year based on target age group is used. Concept: The indicator shows the percentage of children 12-23 months who received specific vaccines at any time before the survey by type of Vaccine and All basic vaccines. |
| Unit of measure |
Percent |
| Classifications |
None |
| Data sources |
The Uganda Demography and Health Survey (UDHS) |
| Data collection method |
Sample Design: The sample design for the 2016 UDHS used the sampling frame from the Uganda National Population and Housing Census (NPHC 2014).The census frame is a complete list of all census Enumeration Areas (EAs) created for the 2014 NPHC. In Uganda, an EA is a geographic area that covers an average of about 130 households. At the time of the NPHC, Uganda was divided administratively into 112 districts, which were grouped for this survey into 15 regions. The sample for the 2016 UDHS was designed to provide estimates of key indicators for the country as a whole, for urban and rural areas separately, and for each of the 15 sub regions. Estimates are also presented for three special areas: the Lake Victoria islands, the mountainous districts, and greater Kampala. The 2016 UDHS sample was stratified and selected in two stages. In the first stage, 697 EAs were selected from the 2014 NPHC, 162 EAs in urban areas and 535 in rural areas. Households constituted the second stage of sampling. A listing of households was compiled in each of the 696 accessible selected EAs from April to October 2016. To minimize the task of household listing, each large EA (that is to say more than 300 households) selected for the 2016 UDHS was segmented. Only one segment was selected for the survey with probability proportional to segment size, and the household listing was conducted only in the selected segment. Out of the 20,880 selected households (30 households per EA), 18,506 women aged 15-49 were successfully interviewed. All women age 15-49 who were either permanent residents of the selected households or visitors who stayed in the household the night before the survey were eligible to be interviewed. In one-third of the sampled households, all men age 15-54, including both usual residents and visitors who stayed in the household the night before the interview, were eligible for individual interviews. Training and data collection: UBOS recruited and trained field staff to serve as supervisors, CAPI managers, interviewers, health technicians, and reserve interviewers for the main fieldwork. Health technicians were trained separately from interviewers. A two-day f ield practice was organized to provide trainees with additional hands on practice before the actual fieldwork. Prior to the main field work, a pre-test was conducted and best practices were adopted. Questionnaires: Four questionnaires were used for the 2016 UDHS: The Household Questionnaire, the Woman’s Questionnaire, the Man’s Questionnaire, and the Biomarker Questionnaire. The questionnaires, based on The DHS Program’s model questionnaires, were adapted to reflect the population and health issues relevant to Uganda. The Input was solicited from all stakeholders such as; Government Ministries and Agencies, Non-governmental Organizations, and Development partners. After the finalization of the questionnaires in English, they were then translated into eight major local languages. The Household, Woman’s, and Man’s Questionnaires were programmed into a computer-assisted personal interviewing (CAPI) application for data collection purposes. Data collection: Data collection was conducted by 21 field teams, each consisting of one team leader, one field data Manager, three female interviewers, one male interviewer, one health technician, and a driver. The health technicians were responsible for anthropometric measurements, blood sample collection for Hemoglobin and malaria testing, and DBS specimen collection for vitamin A testing. The, interviewers used tablets to record all questionnaire responses during the interviews. The tablets were equipped with Bluetooth technology to enable remote electronic transfer of files, such as assignments from the team supervisor to the interviewers, individual questionnaires among survey team members, and completed questionnaires from interviewers to team supervisors. The field supervisors transferred data to the central data processing office via Internet File Streaming System (IFSS). Senior staff from the Makerere University School of Public Health, the Ministry of Health, and UBOS and a survey technical specialist from the DHS Program coordinated and supervised fieldwork activities. Data collection took place over a 6-month period from June 2016 through December 2016. |
| Data collection calendar |
Every 5 years |
| Data release calendar |
2022 |
| Data providers |
Uganda Bureau of Statistics |
| Data compilers |
Uganda Bureau of Statistics, ICF |
| Institutional mandate |
The Uganda Bureau of Statistics (UBOS) Act, 1998 provides for the development and maintenance of a National Statistical System (NSS) to ensure collection, analysis and publication of integrated, relevant, reliable and timely statistical information. It established the Bureau as the coordinating, monitoring and supervisory body for the National Statistical System. |
| Rationale |
This indicator aims to measure access to vaccines, including the newly available or underutilized vaccines, at the national level. In the past decades all countries added numerous new and underutilized vaccines in their national immunization schedule and there are several vaccines under final stage of development to be introduced by 2030. For monitoring diseases control and impact of vaccines it is important to measure coverage from each vaccine in national immunization schedule and the system is already in place for all national programs, however direct measurement for proportion of population covered with all vaccines in the program is only feasible if the country has a well-functioning national nominal immunization registry, usually an electronic one that will allow this coverage to be easily estimated. While countries will develop and strengthen immunization registries it is a need for an alternative measurement. |
| Comment and limitations |
Non |
| Method of computation |
Percentage of children age 12-23 months and children age 24-35 months who received specific vaccines at any time before the survey according to vaccination card, according to mother’s report, according to either vaccination card or mother’s report, and percentage who received specific vaccines by appropriate age. For children age 12-23 months: BCG, HepB (birth dose), 3 doses of DPT-HepB-Hib, 3[4] doses of polio vaccine, 3 [2] doses of pneumococcal vaccine, 3[2] doses of rotavirus vaccine, and 1 dose of MCV, according to the national vaccination schedule. For children age 24 35 months, BCG, HepB (birth dose), 3 doses of DPT-HepB-Hib, 3 [4] doses of polio vaccine, 3 [2] doses of pneumococcal vaccine, 3 [2] doses of rotavirus vaccine, and 2 doses of MCV, according to the national vaccination schedule. |
| Validation |
A wide consultative process is undertaken to compile, assess and validate data on the indicator. The consultation process solicited feedback directly from other Government Agencies responsible for official statistics, on the compilation of the indicators, including the data sources used, and the application of internationally agreed definitions, classification and methodologies to the data from that source. The results of this Indicator consultation are reviewed by Ministry of Gender and UNICEF |
| Methods and guidance available to countries for the compilation of the data at the national level |
Non |
| Quality management |
1. The survey implementation is overseen by a Technical Working Group which is constituted using a multi sectorial approach. 2. The survey report is reviewed by an experienced team at Management level who are in most cases Directors or Heads of departments and key stakeholders from Makerere School of Public Health, Molecular Laboratory of Makerere University School of Health Sciences, Ministry of Health and later reviewed by consultants. |
| Quality assurance |
The 2019/20 UNHS underwent several stages before production and sharing of the final findings. During the Survey implementation.
|
| Quality assessment |
Before dissemination, the report is reviewed and quality assured by a professional team of the National Statistical System. Quality Control is addressed at all levels during Survey implementation |
| Data availability and disaggregation |
Data Availability: Data available Every 5 years Time Series: 2001,2006,2011,2016 Disaggregation: By vaccine type, source of information( Vaccine card, mother to the child), sex, residence, Region, special areas, Mother’s education, wealth quintile. |
| Comparability/deviation from international standards |
• Coverage of HPV vaccine (last dose in the schedule) data is not available. • Coverage of Pneumococcal conjugate vaccine (last dose in the schedule) is only available for series 2016. |
| References and Documentation |
Uganda Demographic and Health Survey 2016 [FR333] (ubos.org) https://dhsprogram.com/ |
| Metadata last updated | Feb 12, 2026 |